# Gut Microbiome in Fecal Samples From Patients With Metastatic Cancer Undergoing Chemotherapy or Immunotherapy

> **NCT02960282** · — · TERMINATED · sponsor: **University of Southern California** · enrollment: 21 (actual)

## Conditions studied

- Metastatic Carcinoma
- Stage IV Colorectal Cancer
- Stage IVA Colorectal Cancer
- Stage IVB Colorectal Cancer

## Interventions

- **PROCEDURE:** Biospecimen Collection
- **OTHER:** Laboratory Biomarker Analysis

## Key facts

- **NCT ID:** NCT02960282
- **Lead sponsor:** University of Southern California
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2016-10-20
- **Primary completion:** 2022-04-13
- **Final completion:** 2022-04-13
- **Target enrollment:** 21 (ACTUAL)
- **Why stopped:** Slow accrual
- **Last updated:** 2022-08-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02960282

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02960282, "Gut Microbiome in Fecal Samples From Patients With Metastatic Cancer Undergoing Chemotherapy or Immunotherapy". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT02960282. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*